Thimble Mindfulness App and Recovery Patch Descriptions

NCT ID: NCT05980247

Last Updated: 2025-04-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-01

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to lessen the pain and fear of needles by using a mindfulness-based app and a recovery patch on pediatric patients between the ages of 5 and 11. The main questions it aims to answer are:

* Can guided mindfulness practices lessen the fear of needles experienced among pediatric patients?
* Can a recovery patch with natural ingredients lessen the pain derived from needle-based procedures when placed on the site of the needle wound?

Participants will be asked to be part of a clinical trial in which they will be picked to be in one of four groups: control (no use of the patch or app), use of Thimble Mindfulness App only (Experimental- App), use of Thimble Recovery Patch only (Experimental-Patch), or use of both Thimble Mindfulness App and Recovery Patch (Experimental-Patch and App). Patients will be asked to:

* Complete a survey at enrollment (demographics + State-Trait Anxiety Inventory for Children (STAI-C))
* If the experimental group with the app, they will use the app before, during, and after their needle-based procedure.
* Complete another survey immediately before needle procedure (STAI-C survey)
* If in experimental group with the patch, they will allow the doctor or nurse to apply the Recovery Patch on the site of the needle wound.
* Complete a survey immediately after needle procedure (STAI-C survey) and app/patch feedback (if assigned to app and/or patch group)
* Complete another survey 24-48 hours after needle procedure (STAI-C survey) and app/patch feedback (if assigned to app and/or patch group) Researchers will compare the 4 groups to see if these interventions (alone or together) improve anxiety and pain associated with needle-based procedures within the pediatric population.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

* This study aims to provide patients with a tool to reduce needle anxiety and establish healthy coping habits when addressing and managing fear. In addition, we will examine the utility of a plant-based post procedure patch in lessening the pain and anxiety that may stem from needle procedures.
* Patients between the ages of 5 and 11 undergoing needle-based procedures will be invited to participate. Patients will be randomized into one of four groups: control (no intervention), intervention (app), intervention (patch), or intervention (app+patch). Children and their caregivers will fill out a secure, online-based survey that includes a demographics (age, gender, ethnicity, zip code) and validated anxiety measure tool S-STAI. They will then, those who are randomized to the groups using the app will scan a QR code to quickly access the web-based app on their mobile device or through a clinic-owned iPad. They will be able to interact with the app as desired; before/during/after the needle-based procedure.
* The app opens with a note of validation presented by an inclusive character and then allows the user to choose where they are in the appointment process: Is it coming up, is it right now, or is it all done? In the preparation section one finds informative animations about how to prepare for needle procedures. Here, clear, honest language is utilized to calmly inform the child of what will take place so that expectations are managed. We encourage the child to choose an ideal comfort position and discuss their needs with the caregiver. This section can be used in the days, hours, or minutes leading up to the visit.
* Next, the platform offers steps to take during the visit. There are three steps outlined but the user can choose any module at any time. Steps 1 and 2 include exercises with engaging animations that utilize applied muscle tension techniques and breathing techniques to help relax the child. Step 3 includes an interactive short, winnable game, which is best used during the procedure to distract the child from the needle.
* Once the procedure is done, the user clicks on the after section where we celebrate and affirm the child's accomplishment. We encourage caregivers to share this proud moment with their friends and family, with the hopes of creating some virality in this movement. The "After" section is a combination of positive reinforcement, a chance to reflect on the experience, and eventually sharing success on social media.
* The post-intervention surveys will ask participants if they would be willing/interested in a short-semi-structured interview. If patients express interest, they will set up a virtual interview time/date with the research team to meet with Dr. Dawkins and Dr. Edison.
* The Recover Patch contains Arnica montana(14%), Curcuma longa (turmeric) (8.1%), Piper nigrum (black pepper)(1.0%), CoQ10 (0.3%), and acrylic adhesive (76%). The Thimble patch will be placed on the site of the needle procedure for those who are placed in the intervention arms that include the Thimble patch. Patients who receive the patch will be instructed to wear the patch for 8-48 hours total.
* After the use of the app and after their needle-based procedure, they will fill out the validated anxiety measurement tool again for post-comparison. They will also be asked to undergo an optional short semi-structured interview.
* The healthcare staff involved in providing the needle-based procedure will also be given a survey to complete to provide their feedback on the effectiveness of the app and how it impacted the appointment overall.
* Participants will also provide their email to which the post-procedure survey will be sent 24 hours after their visit. This survey aims to gather their thoughts of the clinic visit/app and/or patch the day after their needle procedure while also measuring their anxiety and pain levels.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Needle Fear Vaccine Hesitancy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

One control group and three intervention groups.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

No application and no thimble patch.

Group Type NO_INTERVENTION

No interventions assigned to this group

Use of the thimble application but not the thimble patch

Use of the thimble application but not the thimble patch

Group Type EXPERIMENTAL

Thimble Application

Intervention Type DEVICE

Use of of thimble application to practice mindfulness before needle procedure.

Use of the thimble patch but not the thimble application

Use of the thimble patch but not the thimble application

Group Type EXPERIMENTAL

Thimble Application

Intervention Type DEVICE

Use of of thimble application to practice mindfulness before needle procedure.

Use of both thimble application and thimble patch

Use of both thimble application and thimble patch

Group Type EXPERIMENTAL

Thimble Application

Intervention Type DEVICE

Use of of thimble application to practice mindfulness before needle procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Thimble Application

Use of of thimble application to practice mindfulness before needle procedure.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients between the ages of 5 and 11 undergoing a needle-based procedure. (eg. vaccination administration, medication administration, blood draws)
* Parents over the age of 18 years.
* Patients with the cognitive ability to use and navigate the app.
* Patients with non-complex outpatient procedures
* English-speaking patients
* Healthcare staff performing needle-based procedures

Exclusion Criteria

* Patients under the age of 5 or older than 12. Patients who are not undergoing a needle-based procedure.
* Pregnant women, prisoners, and adults unable to consent will not be included in this study.
* Patients lacking the cognitive ability to use and navigate the app
* Patients undergoing needle-based procedure as part of a more complex or inpatient procedure.
* Patients speaking any other language other than English.
* Healthcare staff other than those performing the needle-based procedures.
* Patients who report an allergy to any of the ingredients listed in the Thimble Recovery Patch
Minimum Eligible Age

5 Years

Maximum Eligible Age

11 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Thimble Health

UNKNOWN

Sponsor Role collaborator

Bianca Edison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bianca Edison

Principal Investigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bianca Edison, MD

Role: PRINCIPAL_INVESTIGATOR

Children's Hospital Los Angeles

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's Hospital Los Angeles

Los Angeles, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHLA-23-00176

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.